Transgenic frogs

The binary Gal4–UAS system has been used to drive the tissue-specific expression of transgenes in a number of animal models. In the February 5 issue of Proceedings of the National Academy of Sciences, Katharine Hartley and colleagues at the Wellcome/CRC Institute Cambridge, UK, report application of the Gal4–UAS system to create transgenic Xenopus (Proc Natl Acad Sci USA 2002, 99:1377-1382).The authors generated Xenopus lines expressing constructs for the 'activator', the yeast trans

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The binary Gal4–UAS system has been used to drive the tissue-specific expression of transgenes in a number of animal models. In the February 5 issue of Proceedings of the National Academy of Sciences, Katharine Hartley and colleagues at the Wellcome/CRC Institute Cambridge, UK, report application of the Gal4–UAS system to create transgenic Xenopus (Proc Natl Acad Sci USA 2002, 99:1377-1382).

The authors generated Xenopus lines expressing constructs for the 'activator', the yeast transcription factor Gal4, or 'effector', tandem repeats of the yeast Gal4-binding motif (UAS). In this way they could drive tissue-specific, or stage-specific, transgene expression. Hartley et al. used the Gal4–UAS system to regulate expression of the ventralizing homeobox gene Xvent-2, resulting in severe developmental and microcephalic phenotypes. They propose that such misexpression studies will be useful for extensive gain-of-function experiments in Xenopus.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jonathan Weitzman

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio